Treatment
Drug clinical trials
We’re tracking 1,297 recruiting studies that include Drug, each written for real people, not researchers, below.
Recruiting studies
- NCT06874452RecruitingPhase 4
Anti-anxiety pill for second cataract surgery
This study tests if giving the anti-anxiety pill alprazolam (XANAX) before your second cataract surgery helps reduce anxiety and improve satisfaction with the procedure.
TaipeiAges 18–80 - NCT07189364Enrolling by invitation
Comparing antibiotic prescribing to help doctors improve
This trial tests whether giving doctors a report comparing their antibiotic prescribing to their peers can improve how antibiotics are used. If you are a general medicine patient who stayed in the hospital for a short time, this study may help make antibiotic use safer and more effective.
Toronto, OntarioAges 18 years+ - NCT06545877Recruiting
Survey of REKOVELLE for fertility treatment
This survey collects information from people who have already used REKOVELLE (a medication that helps the ovaries produce eggs) as part of their fertility treatment. Taking part will help researchers learn how the medication works in real-world daily practice.
Omitama, IbarakiAges Any age - NCT07181499RecruitingPhase 2
Chemotherapy with befotertinib for resistance to targeted lung cancer drugs
This trial tests a combination of chemotherapy and a targeted drug (befotertinib) for people with non-small cell lung cancer whose cancer has stopped responding to a common type of targeted therapy. It aims to see if this new sequence can help overcome resistance.
Guangzhou, GuangdongAges 18 years+ - NCT07162779Enrolling by invitation
New PET scan for advanced prostate cancer patients
This trial tests a new type of PET scan using a radioactive tracer called [68Ga]DOTA-IR-780-C-4 to see if it can find prostate cancer cells that express a protein called PSMA. If you have advanced prostate cancer that has stopped responding to standard treatments, this scan may help your doctor better understand your cancer and possibly guide future care.
Wuxi, JiangsuAges 18–80 - NCT07138326Recruiting
Medication absorption in people with an ostomy
This trial looks at how well your body absorbs certain medications if you have an ileostomy or colostomy. It aims to help doctors better understand dosing for people with ostomies.
Vienna, State of ViennaAges 18 years+ - NCT07127835Recruiting
Comparing nurse-led and allergist-led penicillin allergy testing
This study compares two ways of evaluating penicillin allergies: one where a nurse works with an allergist, and another where only an allergist does the evaluation. If you have a penicillin allergy on record, this trial may help find out which approach works better.
Hong KongAges 18 years+ - NCT06597721RecruitingPhase 1
ADCE-T02 for advanced solid tumors
This trial tests a new drug called ADCE-T02, which is an antibody-drug conjugate designed to target and deliver a chemotherapy payload to cancer cells that have a protein called tissue factor. The study is for people with advanced solid tumors that have not responded to other treatments, and it aims to see if the drug is safe and effective.
Rogers, ArkansasAges 18 years+ - NCT07117318Recruiting
NSAIDs with or without a pancreatic stent to prevent pancreatitis after ERCP
This trial tests whether using rectal NSAIDs (a type of painkiller) with or without a small tube (stent) in the pancreas can prevent pancreatitis after ERCP. It's for people who are at higher risk for this complication.
Beijing, Beijing MunicipalityAges 18–90 - NCT05798845RecruitingPhase 2
Toripalimab plus radiation before surgery for stage II–IIIA lung cancer
This trial studies whether adding toripalimab (an immunotherapy medicine) to radiation can improve outcomes for people with operable stage II to IIIA non-small cell lung cancer. It’s designed for cancers that can be fully removed with surgery, and it aims to see if this combination helps more than radiation alone/standard care.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT07231458RecruitingPhase 1
Testing a new immunotherapy with pembrolizumab for advanced solid tumors
This trial tests ABX-001, a new immunotherapy, alone or with pembrolizumab, for people with advanced solid tumors that have not responded to or cannot tolerate standard treatments. It may help if your tumor has become resistant to previous immunotherapies.
BerlinAges 18 years+ - NCT07091123RecruitingPhase 4
Comparing two treatments for chronic back pain after surgery
This study compares two treatments for long-term back pain after surgery: a spinal cord stimulator (a device that sends mild electrical pulses to your spine) and a pump that delivers pain medicine directly to your spinal fluid. It will look at which treatment you prefer and how well it works over time.
Cleveland, OhioAges 30 years+ - NCT07054775RecruitingPhase 4
Comparing itching after two doses of spinal morphine in C-section
This study compares two low doses of morphine given during spinal anesthesia for planned cesarean sections, to see which causes less itching. It aims to find a safer way to manage pain after birth.
Khon KaenAges 18–45 - NCT06816342RecruitingPhase 4
Emergency spacers vs. traditional spacers for asthma
This trial tests whether an emergency-use spacer works as well as a traditional spacer for delivering asthma medication through an inhaler. It may help people with mild to moderate asthma breathe better during an attack.
Banī Suwayf, EgyptAges 6–80 - NCT06756139Recruiting
Mobile app therapy for stubborn stomach upset
This study tests if a mobile app teaching cognitive behavioral therapy (a way to change thinking patterns) can help people with stubborn stomach pain or discomfort. It might benefit those whose symptoms haven't improved with usual medicines.
Haikou, HainanAges 18–80 - NCT07007468Recruiting
Preventing constipation in cancer patients on chemo
This trial tests a way to prevent constipation caused by chemotherapy for breast or lung cancer. It may help if you have hard, difficult-to-pass stools (Bristol type 1 or 2) within five days of treatment.
Istanbul, MarmaraAges 18 years+ - NCT06595290Recruiting
Faster medication increase for heart failure with weak pumping
This trial tests a new, faster way to increase heart failure medications during a hospital stay, aiming to get patients on the right doses sooner. It is for people with weak heart pumping (ejection fraction 40% or less) who are currently in the hospital for heart failure and are on low doses of standard medications.
Long Xuyen, An GiangAges 18–75 - NCT06995261Recruiting
Follitropin delta in a long hormone-suppression IVF cycle
This trial tests a fertility drug called follitropin delta for women undergoing IVF. It checks if using this drug with a specific hormone-lowering protocol helps produce eggs for fertilisation.
Düsseldorf, North Rhine-WestphaliaAges 18–44 - NCT07690358Recruiting
Nitrous oxide levels in body after different exposures
This study measures how much nitrous oxide (laughing gas) stays in your blood, breath, and urine after different types of exposure. It helps researchers understand how long the gas remains in the body for safety reasons.
AarhusAges 18–65 - NCT06814054Recruiting
Predicting low blood pressure after anesthesia in older patients
This study uses ultrasound measurements of the carotid artery and vena cava to predict if older patients might experience low blood pressure after going under general anesthesia for elective surgery. If successful, it could help doctors take preventive steps.
Tanta, El GharbyiaAges 65 years+ - NCT05236595Enrolling by invitation
Personalized study for rare genetic diseases using genetic “target” drugs
This study looks for rare genetic conditions where a personalized genetic medicine (an antisense drug) could potentially work. If the team finds a “targetable” DNA or RNA change in your family, you may be followed to see how the best therapy could be planned.
Scottsdale, ArizonaAges Any age - NCT06915142RecruitingPhase 2
Study of HRS-7058 combined with cancer drugs for advanced solid tumors
This trial tests a new drug, HRS-7058, combined with other anti-cancer drugs for people with advanced solid tumors that cannot be surgically removed. The goal is to see if the combination can shrink tumors or slow their growth.
Beijing, Beijing MunicipalityAges 18–75 - NCT06904820Recruiting
Hepatitis and HIV screening for drug users
This trial tests a convenient way to screen people who use drugs or are in vulnerable situations for hepatitis B, C, and HIV using rapid tests and a liver scanner. The goal is to see if offering these tests in community settings (like shelters or mobile clinics) is acceptable and works well.
LimogesAges 18 years+ - NCT04942886Enrolling by invitation
Preventing hepatitis B reactivation after stem cell transplant
This trial tests whether taking the antiviral medicine entecavir before and after a stem cell transplant can prevent hepatitis B from “waking up” again. It may help protect your liver during a high-risk treatment period.
SeoulAges 19–70
Common questions
- Are there clinical trials studying Drug?
- Yes. Clin2 currently lists 1,297 recruiting studies that include Drug, drawn from the U.S. registry and rewritten for real people so you can see what each is testing and who it's for.
- How do I know if I qualify for a Drug trial?
- Each study lists its own eligibility criteria — rules about condition, age, and prior treatments. On every Clin2 trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Is Drug an approved treatment?
- A drug being studied in a trial may be investigational (still being tested) or already approved and being studied for a new use. Each study page explains what phase it's in. Clin2 does not provide medical advice — talk with your doctor about whether Drug or a specific trial is right for you.
Related treatments
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. A drug appearing here is being studied in a trial and may be investigational. Talk with your doctor about whether a specific treatment or trial is right for you.